Proteoglycans and glycoproteins |
|
|
|
|
|
Fibronectin |
FINC_HUMAN |
263 |
210 ± 15 |
336 ± 16 |
≥0.0001 |
Perlecan |
PGBM_HUMAN |
469 |
323 ± 13 |
176 ± 43 |
0.0280 |
Versican |
CSPG2_HUMAN |
373 |
190 ± 5 |
84 ± 18 |
0.0010 |
Aggrecan |
PGCA_HUMAN |
250 |
154 ± 23 |
28 ± 11 |
0.0003 |
Prolargin |
PRELP_HUMAN |
44 |
76 ± 8 |
86 ± 8 |
0.3100 |
Tenascin |
TENA_HUMAN |
241 |
11 ± 1 |
144 ± 21 |
≥0.0001 |
Biglycan |
PGS1_HUMAN |
42 |
74 ± 4 |
78 ± 10 |
0.4400 |
Vitronectin |
VTNC_HUMAN |
54 |
26 ± 2 |
117 ± 12 |
≥0.0001 |
Decorin |
PGS2_HUMAN |
40 |
35 ± 7 |
70 ± 14 |
0.0430 |
Clusterin |
CLUS_HUMAN |
52 |
34 ± 2 |
69 ± 7 |
≥0.0001 |
Periostin |
POSTN_HUMAN |
93 |
56 ± 6 |
47 ± 6 |
0.6400 |
Lactadherin |
MFGM_HUMAN |
43 |
60 ± 12 |
39 ± 11 |
0.2400 |
Lumican |
LUM_HUMAN |
38 |
41 ± 2 |
51 ± 6 |
0.1400 |
Thrombospondin-1 |
TSP1_HUMAN |
129 |
2 ± 1 |
90 ± 12 |
≥0.0001 |
Tenascin-X |
TENX_HUMAN |
464 |
31 ± 1 |
39 ± 10 |
0.3600 |
Nidogen-1 |
NID1_HUMAN |
136 |
29 ± 4 |
24 ± 7 |
0.6700 |
Aortic carboxypeptidase-like protein |
AEBP1_HUMAN |
131 |
21 ± 2 |
28 ± 6 |
0.2900 |
Laminin subunit gamma 1 |
LAMC1_HUMAN |
178 |
26 ± 6 |
16 ± 6 |
0.3300 |
Mimecan |
MIME_HUMAN |
34 |
15 ± 2 |
23 ± 8 |
0.3200 |
Laminin subunit beta 2 |
LAMB2_HUMAN |
196 |
23 ± 4 |
12 ± 4 |
0.0960 |
Dermatopontin |
DERM_HUMAN |
24 |
17 ± 5 |
16 ± 3 |
0.8100 |
Annexin A2 |
ANXA2_HUMAN |
39 |
13 ± 2 |
19 ± 5 |
0.2600 |
Hyaluronan and proteoglycan link protein 1 |
HPLN1_HUMAN |
40 |
25 ± 9 |
6 ± 2 |
0.0510 |
Fibrillin-1 |
FBN1_HUMAN |
312 |
4 ± 1 |
26 ± 4 |
≥0.0001 |
Laminin subunit alpha 5 |
LAMA5_HUMAN |
400 |
19 ± 4 |
6 ± 2 |
0.0060 |
Fibulin-5 |
FBLN5_HUMAN |
50 |
14 ± 3 |
3 ± 1 |
0.0110 |
Metalloproteinase inhibitor 3 |
TIMP3_HUMAN |
24 |
3 ± 1 |
14 ± 3 |
0.0067 |
Galectin-1 |
LEG1_HUMAN |
15 |
9 ± 3 |
8 ± 2 |
0.9900 |
Asporin |
ASPN_HUMAN |
43 |
2 ± 1 |
12 ± 5 |
0.0800 |
EMILIN-1 |
EMIL1_HUMAN |
107 |
8 ± 3 |
3 ± 1 |
0.1700 |
Microfibril-associated glycoprotein 4 |
MFAP4_HUMAN |
29 |
9 ± 2 |
2 ± 1 |
0.0120 |
Nidogen-2 |
NID2_HUMAN |
151 |
2 ± 0 |
7 ± 3 |
0.0630 |
Fibromodulin |
FMOD_HUMAN |
43 |
5 ± 2 |
3 ± 0 |
0.3700 |
Fibulin-1 |
FBLN1_HUMAN |
77 |
6 ± 2 |
1 ± 0 |
0.0110 |
Agrin |
AGRIN_HUMAN |
215 |
4 ± 2 |
3 ± 1 |
0.5700 |
Thrombospondin-2 |
TSP2_HUMAN |
130 |
ND |
7 ± 1 |
≥0.0001 |
Microfibrillar-associated protein 5 |
MFAP5_HUMAN |
20 |
3 ± 1 |
3 ± 1 |
0.5400 |
Glia-derived nexin |
GDN_HUMAN |
44 |
ND |
4 ± 1 |
0.0014 |
Laminin subunit beta 1 |
LAMB1_HUMAN |
198 |
ND |
4 ± 1 |
0.0110 |
RPE-spondin |
RPESP_HUMAN |
30 |
4 ± 2 |
1 ± 1 |
0.0330 |
Podocan |
PODN_HUMAN |
69 |
ND |
3 ± 1 |
0.0700 |
Matrix Gla proteinc
|
MGP_HUMAN |
12 |
1 ± 0 |
1 ± 1 |
0.7500 |
Sclerostin |
SOST_HUMAN |
24 |
1 ± 0 |
ND |
0.1800 |
SPARC-like protein 1c
|
SPRL1_HUMAN |
75 |
1 ± 1 |
ND |
0.1100 |
Cartilage oligomeric matrix protein |
COMP_HUMAN |
83 |
1 ± 1 |
ND |
0.0930 |
Matrilin-2 |
MATN2_HUMAN |
107 |
1 ± 0 |
1 ± 1 |
0.7900 |
Galectin-3 |
LEG3_HUMAN |
26 |
1 ± 1 |
ND |
0.2700 |
Spondin-1 |
SPON1_HUMAN |
91 |
1 ± 1 |
ND |
0.1300 |
Cartilage acidic protein 1c
|
CRAC1_HUMAN |
71 |
ND |
1 ± 1 |
0.2100 |
SPARC-related modular calcium-binding protein 2 |
SMOC2_HUMAN |
50 |
1 ± 0 |
ND |
0.3200 |
Fibronectin type III domain-containing protein 1 |
FNDC1_HUMAN |
205 |
1 ± 0 |
ND |
0.2300 |
Laminin subunit alpha 4 |
LAMA4_HUMAN |
203 |
1 ± 0 |
ND |
0.3000 |
Hemicentin-1 |
HMCN1_HUMAN |
613 |
ND |
1 ± 0 |
0.4100 |
ECM-associated proteins |
|
|
|
|
|
Serum amyloid P component |
SAMP_HUMAN |
25 |
39 ± 6 |
91 ± 20 |
0.0220 |
Apolipoprotein B-100 |
APOB_HUMAN |
516 |
ND |
96 ± 34 |
0.0470 |
Apolipoprotein A-I |
APOA1_HUMAN |
31 |
ND |
50 ± 16 |
0.0230 |
Serine protease HTRA1 |
HTRA1_HUMAN |
51 |
16 ± 4 |
19 ± 7 |
0.7600 |
TGF-beta induced protein ig-h3 |
BGH3_HUMAN |
75 |
8 ± 3 |
27 ± 4 |
≥0.0001 |
Insulin-like growth factor-binding protein 7 |
IBP7_HUMAN |
29 |
20 ± 2 |
9 ± 3 |
0.0430 |
EGF-containing fibulin-like extracellular matrix protein 1 |
FBLN3_HUMAN |
55 |
13 ± 2 |
12 ± 5 |
0.9900 |
Cathepsin D |
CATD_HUMAN |
22 |
8 ± 2 |
14 ± 4 |
0.1090 |
Extracellular superoxide dismutase |
SODE_HUMAN |
26 |
18 ± 3 |
5 ± 2 |
0.0020 |
Target of Nesh-SH3 |
TARSH_HUMAN |
119 |
20 ± 4 |
3 ± 1 |
0.0002 |
Metalloproteinase inhibitor 3 |
TIMP3_HUMAN |
24 |
3 ± 1 |
14 ± 3 |
0.0067 |
Apolipoprotein E |
APOE_HUMAN |
36 |
ND |
15 ± 4 |
0.0180 |
Macrophage metalloelastasec
|
MMP12_HUMAN |
54 |
ND |
15 ± 3 |
0.0033 |
Apolipoprotein D |
APOD_HUMAN |
21 |
ND |
13 ± 2 |
0.0035 |
Latent-transforming growth factor beta-binding protein 2 |
LTBP2_HUMAN |
195 |
9 ± 2 |
4 ± 1 |
0.0570 |
Latent-TGF-beta binding protein, isoform 1S |
LTB1S_HUMAN |
153 |
8 ± 2 |
4 ± 2 |
0.3000 |
Ceruloplasmin |
CERU_HUMAN |
122 |
ND |
12 ± 5 |
0.0650 |
Transforming growth factor beta-1-induced transcript 1 protein |
TGFI1_HUMAN |
50 |
10 ± 2 |
1 ± 1 |
0.0003 |
Cathepsin G |
CATG_HUMAN |
29 |
3 ± 2 |
7 ± 2 |
0.0450 |
Chymase |
CMA1_HUMAN |
27 |
7 ± 1 |
3 ± 2 |
0.2700 |
Myeloperoxidase |
PERM_HUMAN |
84 |
ND |
10 ± 3 |
0.0210 |
Neutrophil defensin 1 |
DEF1_HUMAN |
10 |
1 ± 1 |
9 ± 1 |
0.0003 |
LIM and cysteine-rich domains protein 1 |
LMCD1_HUMAN |
41 |
9 ± 2 |
ND |
0.0067 |
Lysyl oxidase homolog 1 |
LOXL1_HUMAN |
63 |
5 ± 2 |
3 ± 1 |
0.2900 |
Galectin-3-binding protein |
LG3BP_HUMAN |
65 |
6 ± 3 |
2 ± 0 |
0.1000 |
Tryptase beta-1 |
TRYB1_HUMAN |
31 |
4 ± 1 |
3 ± 2 |
0.9900 |
Metalloproteinase inhibitor-3 |
TIMP1_HUMAN |
23 |
ND |
6 ± 2 |
0.0270 |
Pigment epithelium-derived factor |
PEDF_HUMAN |
46 |
2 ± 1 |
3 ± 1 |
0.6100 |
Carboxypeptidase-like protein X2 |
CPXM2_HUMAN |
86 |
4 ± 2 |
ND |
0.1600 |
Apolipoprotein A-IV |
APOA4_HUMAN |
45 |
ND |
4 ± 3 |
0.1900 |
Phospholipase A2, membrane associated |
PA2GA_HUMAN |
16 |
2 ± 1 |
2 ± 1 |
0.9300 |
Apolipoprotein L1 |
APOL1_HUMAN |
44 |
ND |
4 ± 2 |
0.1900 |
Protein S100-A9c
|
S10A9_HUMAN |
13 |
ND |
4 ± 1 |
0.0290 |
Latent-transforming growth factor beta-binding protein 4 |
LTBP4_HUMAN |
173 |
3 ± 1 |
ND |
0.0550 |
Procollagen C-endopeptidase enhancer 1 |
PCOC1_HUMAN |
48 |
2 ± 1 |
ND |
0.1700 |
Kallistatin |
KAIN_HUMAN |
49 |
ND |
2 ± 2 |
0.3300 |
Properdin |
PROP_HUMAN |
51 |
1 ± 1 |
1 ± 0 |
0.7500 |
Calreticulin |
CALR_HUMAN |
48 |
1 ± 1 |
1 ± 0 |
0.2900 |
Antileukoproteinase |
SLPI_HUMAN |
14 |
1 ± 0 |
ND |
0.0980 |
Cathepsin Z |
CATZ_HUMAN |
34 |
1 ± 1 |
ND |
0.4800 |
Secreted frizzled-related protein 1 |
SFRP1_HUMAN |
35 |
2 ± 1 |
ND |
0.1200 |
SPARC-like protein 1 |
SPRL1_HUMAN |
75 |
1 ± 1 |
ND |
0.1100 |
Protein S100-A8c
|
S10A8_HUMAN |
11 |
1 ± 0 |
1 ± 0 |
0.4200 |
Secreted frizzled-related protein 3 |
SFRP3_HUMAN |
36 |
1 ± 1 |
ND |
0.1400 |
C-type lectin domain family 11 member Ac
|
CLC11_HUMAN |
36 |
1 ± 0 |
1 ± 0 |
0.9500 |
Lipocalin 1c
|
LCN1_HUMAN |
19 |
ND |
1 ± 0 |
0.1800 |
Secreted phosphoprotein 24 |
SPP24_HUMAN |
24 |
ND |
1 ± 1 |
0.1600 |
EGF-like repeat and discoidin I-like domain- |
|
|
|
|
|
containing protein 3 |
EDIL3_HUMAN |
54 |
ND |
1 ± 1 |
0.2400 |
Insulin-like growth-factor binding protein complex acid labilec
|
ALS_HUMAN |
66 |
ND |
1 ± 0 |
0.2900 |
Collagens |
|
|
|
|
|
Collagen alpha 3(VI) |
CO6A3_HUMAN |
344 |
194 ± 35 |
343 ± 37 |
0.0025 |
Collagen alpha 1(VI) |
CO6A1_HUMAN |
109 |
74 ± 10 |
95 ± 16 |
0.1100 |
Collagen alpha 1(XIV) |
COEA1_HUMAN |
194 |
112 ± 17 |
40 ± 9 |
0.0005 |
Collagen alpha 1(XVIII) |
COIA1_HUMAN |
178 |
69 ± 6 |
13 ± 4 |
≥0.0001 |
Collagen alpha 1(I) |
CO1A1_HUMAN |
139 |
36 ± 5 |
41 ± 2 |
0.0580 |
Collagen alpha 1(XII) |
COCA1_HUMAN |
333 |
17 ± 3 |
60 ± 10 |
0.0006 |
Collagen alpha 2(VI) |
CO6A2_HUMAN |
109 |
35 ± 6 |
40 ± 7 |
0.2400 |
Collagen alpha 2(I) |
CO1A2_HUMAN |
129 |
34 ± 2 |
36 ± 2 |
0.0580 |
Collagen alpha 2(IV) |
CO4A2_HUMAN |
168 |
37 ± 6 |
31 ± 12 |
0.7700 |
Collagen alpha 1(XV) |
COFA1_HUMAN |
142 |
24 ± 6 |
17 ± 5 |
0.4300 |
Collagen alpha 1(V) |
CO5A1_HUMAN |
184 |
8 ± 1 |
11 ± 2 |
0.0300 |
Collagen alpha 1(VIII) |
CO8A1_HUMAN |
73 |
7 ± 2 |
9 ± 3 |
0.6200 |
Collagen alpha 2(VIII) |
CO8A2_HUMAN |
67 |
2 ± 1 |
3 ± 1 |
0.3100 |
Collagen alpha 1(IV) |
CO4A1_HUMAN |
161 |
1 ± 1 |
2 ± 1 |
0.4700 |
Collagen alpha 1(XXI) |
COLA1_HUMAN |
99 |
1 ± 0 |
2 ± 1 |
0.2100 |
Collagen alpha 2(V) |
CO5A2_HUMAN |
145 |
ND |
1 ± 0 |
0.0820 |